CVS Health (CVS)
(Delayed Data from NYSE)
$56.94 USD
+0.47 (0.83%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$56.94 USD
+0.47 (0.83%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth F Momentum C VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Previewing Retail Sector Earnings as Inflation Climbs
by Sheraz Mian
With respect to the Retail sector's 2022 Q1 earnings season scorecard, we now have results from 21 of the 34 retailers in the S&P 500 index. Here's how the companies are performing so far and what to expect...
Here's Why You Should Hold on to CVS Health (CVS) For Now
by Zacks Equity Research
Investors are optimistic about CVS Health's (CVS) better-than-expected results and strong retail sales.
The Zacks Analyst Blog Highlights AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings
by Zacks Equity Research
AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings are part of Zacks top Analyst Blog.
Q1 Earnings Scorecard and Analyst Reports for AbbVie, QUALCOMM & Linde
by Sheraz Mian
Today's Research Daily features a real-time update on the Q1 earnings season and new research reports on AbbVie (ABBV), QUALCOMM (QCOM), and Linde(LIN).
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
CVS Health (CVS) Q1 Earnings Top Estimates, '22 EPS View Up
by Zacks Equity Research
CVS Health (CVS) reports better-than-expected results for Q1, with robust segmental performance driving the top line.
CVS Health (CVS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 3.74% and 1.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Herbalife LTD. (HLF) Q1 Earnings Beat Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 13.79% and 2.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Can CVS Health (CVS) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
TravelCenters of America (TA) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
TravelCenters (TA) delivered earnings and revenue surprises of 2,160% and 4.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $100.85 in the latest trading session, marking a -0.57% move from the prior day.
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Increased digital health adoption and growing pharmacy sales are likely to have contributed to CVS Health's (CVS) Q1 performance.
Is Legg Mason Low Volatility High Dividend ETF (LVHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for LVHD
CVS Health (CVS) Stock Moves -1.37%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $105.18, marking a -1.37% move from the previous day.
Top Research Reports for Johnson & Johnson, Roche & Raytheon
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Roche Holding AG (RHHBY), and Raytheon Technologies Corporation (RTX).
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $103.86, moving +0.43% from the previous trading session.
Rite Aid (RAD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of -185.96% and 2.02%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $104.98, marking a +0.32% move from the previous day.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $104.64, moving +0.18% from the previous trading session.
The Zacks Analyst Blog Highlights Merck, CVS Health, American Tower, QUALCOMM and Analog Devices
by Zacks Equity Research
Merck, CVS Health, American Tower, QUALCOMM and Analog Devices are part of top Analyst article.
Top Analyst Reports for Merck, CVS Health & American Tower
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co. Inc. (MRK), CVS Health Corporation (CVS), and American Tower Corporation (AMT).
CVS Health (CVS) Stock Moves -0.54%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $99.46, moving -0.54% from the previous trading session.
Here's Why You Should Retain CVS Health (CVS) Stock For Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) owing to continued progress in its consumer-centric digital solutions.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $103.55, marking a -1.08% move from the previous day.